Trials / Completed
CompletedNCT01837446
Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer
Evaluating the Effectiveness of Topical Morphine Compared With a Routine Mouthwash in Managing Cancer Treatment-induced Mucositis in Patients With Head and Neck Cancer in Isfahan
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Isfahan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Oral mucositis is a debilitating side effects of cancer treatment for which there is not much successful treatments at yet. The investigators are going to evaluate the effectiveness of topical morphine compared with a routine mouthwash in managing cancer treatment-induced mucositis. The investigators hypothesize that topical morphine is more effective and more satisfied by patients than the magic mouthwash in reducing severity of cancer treatment-induced oral mucositis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 2% morphine solution | |
| DRUG | Magnesium aluminum hydroxide | |
| DRUG | 2% viscous lidocaine | |
| DRUG | Diphenhydramine |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-07-01
- Completion
- 2012-10-01
- First posted
- 2013-04-23
- Last updated
- 2013-04-23
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01837446. Inclusion in this directory is not an endorsement.